ArticleScientific reports2025
Development and validation of a nomogram-based predictive model for recurrence risk of uterine leiomyoma after myomectomy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A logistic regression model for predicting postoperative recurrence of cellular uterine leiomyoma.European journal of obstetrics & gynecology and reproductive biology: X · 2026Article
- Integrating reproductive and metabolic factors for uterine fibroid risk assessment: a two-center machine learning study with SHAP interpretability.Frontiers in oncology · 2026Article
- A multicenter, clinically interpretable prediction model for malignancy risk in C-TIRADS 3-4 thyroid nodules.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uterine fibroids are common among women of reproductive age and often recur after treatment. Accurate recurrence prediction is essential for guiding clinical decisions, yet existing models remain inadequate. This study aimed to develop a nomogram based on Least Absolute Shrinkage and Selection Operator (LASSO) regression to estimate recurrence risk after myomectomy. We retrospectively analyzed data from 678 patients who underwent myomectomy, randomly dividing them into training and validation cohorts (7:3 ratio). LASSO regression was used to select relevant predictors, and a nomogram was constructed. Model performance was evaluated using receiver operating characteristic curves, calibration plots, and decision curve analysis. Six key predictors were identified: leiomyoma subclassification, fibroid diameter ≤ 4 cm, postoperative residual fibroids, postoperative pregnancy or childbirth, family history, and the number of fibroids detected via transvaginal ultrasound. The nomogram demonstrated strong discrimination, calibration, and clinical utility. The proposed nomogram provides a reliable and practical tool for predicting fibroid recurrence, supporting personalized postoperative management and follow-up planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.